Genmab A/S Post-ASCO R&D Update Transcript - Thomson StreetEvents

Genmab A/S Post-ASCO R&D Update Transcript

Genmab A/S Post-ASCO R&D Update Transcript - Thomson StreetEvents
Genmab A/S Post-ASCO R&D Update Transcript
Published Jun 02, 2025
12 pages (6548 words) — Published Jun 02, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of GMAB.CO corporate analyst meeting

  
Brief Excerpt:

...Hello and welcome to a brief review of the energizing data that has recently been presented for Rina-S, including today at the 2025 ASCO Annual Meeting. Next slide. Before we begin, as a reminder, this presentation may contain forward-looking statements and may contain certain risks and uncertainties. Let's move to the next slides. Now to our agenda for today's call. We are encouraged by the recent compelling data that we have seen for Rina-S, both the updated data at PROC -- in PROC that was presented at SGO, and the highly anticipated data in endometrial cancer that was presented just today at ASCO in Chicago. When viewed together, Rina-S looks more and more like a potentially best-in-class treatment for gynecologic cancers, but it also holds promise more broadly in other folate receptor alpha expressing solid tumors. We have with us today our Chief Medical Officer Tahi Ahmadi, who will both review this data and provide you with an update to our robust development plan for Rina-S. I will...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Genmab A/S
Ticker
GMAB.CO
Time
9:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Genmab A/S at Citi Global Healthcare Conference Transcript – 2025-12-04 – US$ 54.00 – Edited Transcript of GMAB.CO presentation 4-Dec-25 2:45pm GMT

Genmab A/S Q3 2025 Earnings Call Transcript – 2025-11-06 – US$ 54.00 – Edited Transcript of GMAB.CO earnings conference call or presentation 6-Nov-25 5:00pm GMT

Genmab A/S at Morgan Stanley Global Healthcare Conference Transcript – 2025-09-09 – US$ 54.00 – Edited Transcript of GMAB.CO presentation 9-Sep-25 11:45am GMT

Genmab A/S Q2 2025 Earnings Call Transcript – 2025-08-07 – US$ 54.00 – Edited Transcript of GMAB.CO earnings conference call or presentation 7-Aug-25 4:00pm GMT

Genmab A/S at Goldman Sachs Global Healthcare Conference Transcript – 2025-06-09 – US$ 54.00 – Edited Transcript of GMAB.CO presentation 9-Jun-25 12:00pm GMT

Genmab A/S Q1 2025 Earnings Call Transcript – 2025-05-08 – US$ 54.00 – Edited Transcript of GMAB.CO earnings conference call or presentation 8-May-25 4:00pm GMT

Genmab A/S Annual Shareholders Meeting Transcript – 2025-03-12 – US$ 54.00 – Edited Transcript of GMAB.CO shareholder or annual meeting 12-Mar-25 1:00pm GMT

Genmab A/S Corporate Call On HexaBody CD38 (GEN3014) Transcript – 2025-03-10 – US$ 54.00 – Edited Transcript of GMAB.CO conference call or presentation 10-Mar-25 4:00pm GMT

Genmab A/S at TD Cowen Healthcare Conference Transcript – 2025-03-03 – US$ 54.00 – Edited Transcript of GMAB.CO presentation 3-Mar-25 6:50pm GMT

Genmab A/S Q4 2024 Earnings Call Transcript – 2025-02-12 – US$ 54.00 – Edited Transcript of GMAB.CO earnings conference call or presentation 12-Feb-25 5:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Genmab A/S Post-ASCO R&D Update Transcript" Jun 02, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Genmab-A-S-Post-ASCO-R-D-Update-T16386401>
  
APA:
Thomson StreetEvents. (2025). Genmab A/S Post-ASCO R&D Update Transcript Jun 02, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Genmab-A-S-Post-ASCO-R-D-Update-T16386401>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.